🇺🇸 FDA
Pipeline program

Wei Li Bai capsules

WLB-2022

Phase 2 small_molecule terminated

Quick answer

Wei Li Bai capsules for Alzheimer Disease is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Alzheimer Disease
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials